Stockscreener 앱 받기
2.00
8.11%
0.15
시간 외 거래:
2.00
전일 마감가:
$1.85
열려 있는:
$1.85
하루 거래량:
2.08M
Relative Volume:
0.89
시가총액:
$92.31M
수익:
$16.77M
순이익/손실:
$-11.87M
주가수익비율:
-4.2176
EPS:
-0.4742
순현금흐름:
$-5.90M
1주 성능:
+21.95%
1개월 성능:
+13.64%
6개월 성능:
+303.39%
1년 성능:
+161.47%
1일 변동 폭
$1.85
$2.12
1주일 범위
$1.64
$2.12
52주 변동 폭
$0.30
$2.41
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
IPA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
2.00 | 87.23M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-10-25 | 개시 | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd 주식(IPA)의 최신 뉴스
Angi (ANGI) Q2 Revenue Beats by 6% - AOL.com
Inmune Bio Inc. shares fall 1.09% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
ImmunoPrecise Antibodies Divests Netherlands Facilities to AVS Bio - citybiz
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript - MSN
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio - MSN
AVS Bio, an Arlington Capital Partners Portfolio Co. Acquires ImmunoPrecise Antibodies Europe - citybiz
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Silicon Canals
ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation - TipRanks
ImmunoPrecise Antibodies sells Netherlands subsidiary to AVS Bio for $12m - Investing.com Australia
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Business Wire
TR | OpenAI4o Initiates ImmunoPrecise Antibodies(IPA.US) With Hold Rating, Announces Target Price $2 - 富途牛牛
Day One (DAWN) Q2 Revenue Jumps 313% - AOL.com
Prothena Q2 Revenue Drops 97% - AOL.com
Agilon Health (AGL) Q2 Revenue Falls 6% - AOL.com
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript - Mitrade
ITRM Reports Results - AOL.com
Idexx (IDXX) Q2 Revenue Jumps 11% - AOL.com
What institutional investors are buying ImmunoPrecise Antibodies Ltd. stockUnstoppable trading performance - Jammu Links News
What catalysts could drive ImmunoPrecise Antibodies Ltd. stock higher in 2025High-yield market plays - Jammu Links News
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for ImmunoPrecise Antibodies Ltd. in the next 12 monthsDynamic growth stocks - Jammu Links News
What drives ImmunoPrecise Antibodies Ltd. stock priceTremendous wealth creation - Jammu Links News
What is ImmunoPrecise Antibodies Ltd. company’s growth strategyExtraordinary market timing - Jammu Links News
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyInvest smarter with advanced market data - Jammu Links News
What are the latest earnings results for ImmunoPrecise Antibodies Ltd.Build a diversified portfolio for maximum returns - Jammu Links News
Why is ImmunoPrecise Antibodies Ltd. stock attracting strong analyst attentionWealth Building Planner With Proven Results - Jammu Links News
ImmunoPrecise Antibodies Announces Details for October 2025 Annual Meeting - TipRanks
Does ImmunoPrecise Antibodies Ltd. stock perform well during market downturnsFinancial News Updates For Consistent Profits - Jammu Links News
What does recent volatility data suggest for ImmunoPrecise Antibodies Ltd.Technical Entry Plan with Risk Minimization - Newser
Is ImmunoPrecise Antibodies Ltd. stock bottoming outFree Accurate Buy Point for Momentum Stocks - Newser
Is ImmunoPrecise Antibodies Ltd. stock ready for a breakoutWeekly Chart-Based Forecast for Traders - Newser
ImmunoPrecise Antibodies Full Year 2025 Earnings: Misses Expectations - sg.finance.yahoo.com
How Efficient Is ImmunoPrecise Antibodies Ltd. at Controlling Operating CostsTechnical Trade Plan with Entry Checklist - Newser
Is ImmunoPrecise Antibodies Ltd. forming a reversal patternFree Swing Setup With Technical Confirmation - Newser
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... By GuruFocus - Investing.com Canada
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Detecting support and resistance levels for ImmunoPrecise Antibodies Ltd.Short Term Opportunity Finder with Tools - Newser
ImmunoPrecise Antibodies Ltd. Reports Strategic Focus Amid Financial Challenges - TipRanks
Immunoprecise Antibodies Q4 2025 Earnings Call Transcript: Financial Performance, Strategic Initiatives, and Operational Highlights - AInvest
ImmunoPrecise Antibodies Reports Record Revenue and Growth - TipRanks
ImmunoPrecise Antibodies Q4 2025 Earnings Call Transcript - MarketBeat
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN
What technical models suggest about ImmunoPrecise Antibodies Ltd.’s comebackFree Fundamental Winners With Safe Entry Plan - Newser
Investors ignore increasing losses at ImmunoPrecise Antibodies (NASDAQ:IPA) as stock jumps 15% this past week - simplywall.st
Earnings call transcript: ImmunoPrecise sees record revenue in Q4 2025 By Investing.com - Investing.com Nigeria
Earnings call transcript: ImmunoPrecise sees record revenue in Q4 2025 - Investing.com
ImmunoPrecise Bets Big On BioStrand Growth And AI Focus - Finimize
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Immunoprecise Antibodies Ltd (IPA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):